Verified & credential-checked
Dr. Priya Raghunathan
PharmD, BCPP, CPGx · Psychiatric Pharmacist / Genetic Specialist
Austin, Texas · 12 years in practice
About
Pharmacogenomics for treatment-resistant patients
Dr. Priya Raghunathan completed a PGY-2 psychiatric pharmacy residency at Seton Healthcare and holds board certification in psychiatric pharmacy along with pharmacogenomics certification through the American Society of Pharmacovigilance.
Her consultations focus on people carrying long, undocumented medication histories — often eight to twelve failed trials over a decade. She reconstructs that history, maps it against CYP2D6, CYP2C19, and SLC6A4 phenotypes, and identifies whether the pattern was metabolic rather than diagnostic.
She works under collaborative practice agreements with prescribers in four states and provides a written medication plan with taper schedules, interaction flags, and monitoring intervals.
Specialties
Approach
A three-phase model, so you know what happens at each stage and what you leave with.
01
Assessment
Full medication timeline reconstruction, pharmacy fill records, and a CYP2D6/2C19/2B6/SLC6A4 panel if none exists.
02
Strategy
A phenotype-matched shortlist with predicted tolerability, ranked alongside what has already failed and why, delivered to both client and prescriber.
03
Execution
Coordination with the prescriber on titration, a 6-week tolerability check, and a 12-week outcome review with rating scales.
What clients say
Eleven medications in nine years. She looked at my panel and said I was a CYP2D6 ultrarapid metabolizer — which explained every single failure. First time anything made sense.
My psychiatrist actually thanked me for bringing her report in. They now co-manage my regimen.
Credentials & Affiliations
American Association of Psychiatric Pharmacists
CPIC Implementation Network
Texas State Board of Pharmacy